MedTrace Logo

Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™

NCT00667511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2015-01-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.

Conditions

  • Kidney Failure, Chronic
  • End-Stage Renal Disease

Interventions

DEVICE

NxStage System One

Comparison of Nocturnal (NHD) and Short Daily Hemodialysis (DHD) with the NxStage System One

Sponsors & Collaborators

  • NxStage Medical

    lead OTHER

Principal Investigators

  • Paul Kravitz · NxStage Medical

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00667511 on ClinicalTrials.gov